meddevicedb.com FDA Device Reference

PRECISION XTRA PLUS OR OPTIUM PLUS, BLOOD GLUCOSE TEST STRIPS

K051213 Class II Special
Decision Date
2005-05-27
Sponsor / Applicant
Abbott Laboratories, Inc.

Technical Specification

510(k) Submission ID K051213
Product Code NBW
Medical Specialty / Panel Clinical Chemistry
Regulation Citation 21 CFR 862.1345
Decision Date 2005-05-27
Clearance Pathway Special

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

PRECISION XTRA PLUS OR OPTIUM PLUS, BLOOD GLUCOSE TEST STRIPS received FDA 510(k) clearance under submission number K051213, sponsored by Abbott Laboratories, Inc.. The device was reviewed via the Special premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2005-05-27.

Classification & Regulation

This clearance is catalogued under FDA product code NBW and 21 CFR 862.1345, within the Clinical Chemistry review panel as a Class II device.